Archimica Overview
- Year Founded
-
1947
- Status
-
Acquired/Merged
- Employees
-
128
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
5
Archimica General Information
Description
Manufacturer of active pharmaceutical ingredients (API) and late-stage intermediates for the pharmaceutical industry. The company's products include reagents and building blocks, regulatory starting materials, cGMP intermediates, and active pharmaceutical ingredients.
Contact Information
Website
www.archimica.com(Operating Subsidiary)
Corporate Office
- Viale Milano, 86
- 26900 Lodi
- Italy
Corporate Office
- Viale Milano, 86
- 26900 Lodi
- Italy
Archimica Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Archimica Comparisons
Industry
Financing
Details
Archimica Competitors (6)
One of Archimica’s 6 competitors is Medichem Spain, a Corporation company based in Sant Joan Despí, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Medichem Spain | Corporation | Sant Joan Despí, Spain | ||||
| Fabbrica Italiana Sintetici | Private Equity-Backed | Vicenza, Italy | ||||
| Dipharma | Corporation | Milan, Italy | ||||
| Erregierre | Corporation | San Paolo D'argon, Italy | ||||
| CPL SACHSE | Corporation | Berlin, Germany |
Archimica Signals
Archimica Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Archimica Investments & Acquisitions (5)
Archimica’s most recent deal was a Buyout/LBO with Archimica (acquired). The deal was made on 14-Feb-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Archimica (acquired) | 14-Feb-2011 | Buyout/LBO | Pharmaceuticals | ||
| Suzhou Tianma Group Tianji Bio-Pharmaceutical Company | 01-Dec-2010 | PE Growth/Expansion | Other Pharmaceuticals and Biotechnology | ||
| Polichimica | 09-Mar-2010 | Buyout/LBO | Distributors (Healthcare) | ||
| Diaspa | 04-Apr-2002 | Merger/Acquisition | Other Commercial Services | ||
| Diaspa | 29-Dec-1997 | Merger/Acquisition | Other Commercial Services |
Archimica Exits (3)
Archimica’s most recent exit was on 01-Dec-2010 from Suzhou Tianma Group Tianji Bio-Pharmaceutical Company. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Suzhou Tianma Group Tianji Bio-Pharmaceutical Company | 01-Dec-2010 | Completed |
|
||
| Diaspa | 04-Apr-2002 | Completed |
|
||
| Diaspa | 29-Dec-1997 | Merger/Acquisition | Completed |
|
Archimica FAQs
-
When was Archimica founded?
Archimica was founded in 1947.
-
Where is Archimica headquartered?
Archimica is headquartered in Lodi, Italy.
-
What is the size of Archimica?
Archimica has 128 total employees.
-
What industry is Archimica in?
Archimica’s primary industry is Pharmaceuticals.
-
Is Archimica a private or public company?
Archimica is a Private company.
-
What is the current valuation of Archimica?
The current valuation of Archimica is .
-
What is Archimica’s current revenue?
The current revenue for Archimica is .
-
How much funding has Archimica raised over time?
Archimica has raised $108M.
-
Who are Archimica’s investors?
Clessidra Private Equity, Curia, DeA Capital Alternative Funds, LÖW, and Mindful Capital Partners are 5 of 6 investors who have invested in Archimica.
-
Who are Archimica’s competitors?
Medichem Spain, Fabbrica Italiana Sintetici, Dipharma, Erregierre, and CPL SACHSE are some of the 6 competitors of Archimica.
-
When was Archimica acquired?
Archimica was acquired on 27-Apr-2023.
-
Who acquired Archimica?
Archimica was acquired by PI Industries.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process